Quercetin and naringenin reduce abnormal development of mouse embryos produced by hydroxyurea

Journal of Pharmacy and Pharmacology

Volumn 62, Issue 8, 2010, Pages 1003-1009

  Pérez Pastén, Ricardo ^a   Martínez Galero, Elizdath ^a   Chamorro Cevallos, Germán ^a  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

flavonoids; hydroxyurea; teratogenesis; whole embryo culture

Indexed keywords

DIMETHYL SULFOXIDE; FLAVONOID; HYDROXYUREA; NARINGENIN; QUERCETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DEVELOPMENTAL, AGE AND GROWTH PARAMETERS; DRUG EFFECT; DRUG POTENCY; EDEMA; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; GROWTH RETARDATION; HYPOPLASIA; IN VITRO STUDY; MALE; MOUSE; MOUSE EMBRYO; NEURAL TUBE DEFECT; NONHUMAN; OXIDATIVE STRESS; PROTECTION; TELENCEPHALON; TERATOGENICITY;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; ANTIOXIDANTS; CYTOPROTECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO CULTURE TECHNIQUES; EMBRYO, MAMMALIAN; EMBRYONIC DEVELOPMENT; FLAVANONES; HYDROXYUREA; MICE; MICE, INBRED ICR; OXIDATIVE STRESS; QUERCETIN; TIME FACTORS;

EID: 77954925611     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2010.01118.x     Document Type: Article

References (57)

1. Anjaneluyu M, Chopra K. Quercetin, an anti-oxidant bioflavonoid, attenuates diabetic nephropathy in rats. Clin Exp Pharmacol Physiol 2004 1 : 244 248.
2. Tripoli E et al. Citrus flavonoids: molecular structure, biological activity and nutritional properties: a review. Food Chem 2007 104 : 466 479.
3. Ross JA, Kasum CM. Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr 2002 22 : 19 34.
4. Kanno S et al. Effects of naringin on hydrogen peroxide induced cytotoxicity and apoptosis in P388 cells. J Pharmacol Sci 2003 92 : 66 70.
5. Kanno S et al. Effects of naringin on cytosine arabinoside (Ara-c)-induced apoptosis in P388 cells. Life Sci 2004 75 : 353 365.
6. Plumb W et al. Antioxidant properties of flavonol glycosides from green beans. Redox Rep 1999 4 : 123 127.
7. Fiorani M et al. Quercetin prevents glutathione depletion induced by dehydroascorbic acid in rabbit red blood cells. Free Radic Res 2001 34 : 639 648.
8. Arai Y et al. Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration. J Nutr 2000 130 : 2243 2250.
9. 2-induced apoptosis via anti-oxidant activity and heme oxygenase 1 gene expression in macrophages. Biochem Pharmacol 2005 69 : 1839 1851.
10. Kampa M et al. Antiproliferative and apoptotic effects of selective phenolic acids on T47D human breast cancer cells: potential mechanisms of action. Breast Cancer Res 2004 6 : R63 R74.
11. Wells PG et al. Molecular and biochemical mechanisms in teratogenesis involving reactive oxygen species. Toxicol Appl Pharmacol 2005 207 : 354 366.
12. Kovacic P, Somanathan R. Mechanism of teratogenesis: electron transfer, reactive oxygen species, and antioxidants. Birth Def Res C 2007 78 : 308 325.
13. DeSesso JM. Cell death and free radicals: a mechanism for hydroxyurea teratogenesis. Med Hypotheses 1979 5 : 937 951.
14. Yan J, Hales B. Depletion of glutathione induces 4-hydroxynonenal protein adducts and hdroxyurea teratogenicity in the organogenesis stage mouse embryo. J Pharmacol Exp Ther 2006 319 : 613 621.
15. Scott W et al. DNA synthesis inhibition and cell death associated with hydroxyurea teratogenesis in rat embryos. Develop Biol 1971 26 : 306 315.
16. DeSesso JM et al. D-mannitol, a specific hydroxyl free radical scavenger, reduces the developmental toxicity of hydroxyurea in rabbits. Teratology 1994 49 : 249 259.
17. DeSesso JM. Amelioration of teratogenesis. I. Modification of hydroxyurea-induced teratogenesis by the antioxidant propyl gallate. Teratology 1981 24 : 19 35.
18. Warner A et al. A comparsion of the in vivo and in vitro response of mammalian embryos to teratogenic insult. Toxicology 1983 28 : 271 282.
19. Zucker RM et al. Apoptosis and morphology in mouse embryos by confocal laser scanning microscopy. Methods 1999 18 : 473 480.
20. Cockroft DL. Dissection and culture of post-implantation embryos. In : Copp AJ, Cockroft DL, eds. Postimplantation Mammalian Embryos. A Practical Approach.
21. Brown N, Fabro S. Quantitation of rat embryonic development in vitro: a morphological scoring system. Teratology 1981 24 : 65 78.
22. Labarca C, Paigen K. A simple, rapid, and sensitive DNA assay procedure. Ann Biochem 1980 102 : 344 352.
23. Skibola C, Smith M. Potential health impacts of excessive flavonoid intake. Free Radic Biol Med 2000 29 : 375 383.
24. Sergediene E et al. Pro-oxidant toxicity of polyphenolic antioxidants to HL-60 cells: description of quantitative structure-activity relationships. FEBS Lett 1999 462 : 392 396.
25. Cortázar T et al. Leishmania panamensis: comparative inhibition of nuclear DNA topoisomerase II enzymes from promastigotes and human macrophages reveals anti-parasite selectivity of fluoroquinolones, flavonoids and pentamidine. Exp Parasitol 2007 116 : 475 482.
26. Irene Crespo M et al. Differential effects of dietary flavonoids on reactive oxygen and nitrogen species generation and changes in antioxidant enzyme expression induced by proinflammatory cytokines in Chang liver cells. Food Chem Toxicol 2008 46 : 1555 1569.
27. Matter W et al. The inhibition of phosphatidylinositol 3-kinase by quercetin and analogs. Biochem Biophys Res Comm 1992 186 : 624 631.
28. Brusselmans K et al. Induction of cancer cell apoptosis by flavonoids is associated with their ability to inhibit fatty acid synthase activity. J Biol Chem 2005 280 : 5636 5645.
29. Casagrande F, Darbon J. Effects of structurally related flavonoids on cell cycle progression of human melanoma cells: regulation of cyclin-dependent kinases CDK2 and CDK1. Biochem Pharmacol 2001 61 : 1205 1215.
30. Moridani MY et al. Comparative quantitative structure toxicity relationships for flavonoids evaluated in isolated rat hepatocytes and HeLa tumor cells. Chem Biol Interact 2002 139 : 251 264.
31. Matsuo M et al. Cytotoxicity of flavonoids toward cultured normal human cells. Biol Pharm Bull 2005 28 : 253 259.
32. Plochmann K et al. Structure-activity relationships of flavonoid-induced cytotoxicity on human leukemia cells. Arch Biochem Biophys 2007 460 : 1 9.
33. Schröder-van der Elst JP et al. Flavonoids cross the placenta in the rat and are found in fetal brain. Am J Physiol 1998 274 : E253 E256.
34. Jang JY et al. Antiteratogenic effects of alpha-naphthoflavone on 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposed mice in utero. Reprod Toxicol 2007 24 : 303 309.
35. Chu KO et al. Pharmacokinetic studies of green tea catechins in maternal plasma and fetuses in rats. J Pharm Sci 2006 95 : 1372 1381.
36. Waalkens-Berendsen DH et al. Embryotoxicity and teratogenicity study with neohesperidin dihydrochalcone in rats. Regul Toxicol Pharmacol 2004 40 : 74 79.
37. Chan WH. Impact of genistein on maturation of mouse oocytes, fertilization, and fetal development. Reprod Toxicol 2009 28 : 52 58.
38. Richter DU et al. Effects of phytoestrogens genistein and daidzein on progesterone and estrogen (estradiol) production of human term trophoblast cells in vitro. Gynecol Endocrinol 2009 25 : 32 38.
39. Barrach H et al. The applicability of the in vitro systems for the evaluation of the significance of pharmacokinetic parameters for the induction of an embryotoxic effect. In : Neubert D et al., eds. Role of Pharmakokinetics in Prenatal and Perinatal Exposure, 3rd Symposium on Prenatal Development.
40. Felgines C et al. Bioavailability of flavonone naringenin and its glycosides in rats. J Am Physiol 2000 279 : G1148 G1154.
41. Russo A et al. Bioflavonoids as antiradicals, antioxidants and DNA clevage protectors. Cell Biol Toxicol 2000 16 : 91 98.
42. Hollman PC, Katan MB. Bioavailability and health effects of dietary flavonols in men. Arch Toxicol Suppl 1998 20 : 237 248.
43. Conquer JA et al. Supplementation with quercetin markedly increases plasma quercetin concentration without effect on selected risk factors for heart disease in healthy subjects. J Nutr 1998 128 : 593 597.
44. Willhite C. Teratogenic potential of quercetin in the rat. Food Chem Toxicol 1982 20 : 75 79.
45. Erlund I et al. Plasma concentrations of the flavonoids hesperetin, naringenin and quercetin in human subjects following their habitual diets, and diets high or low in fruit and vegetables. Eur J Clin Nutr 2002 56 : 891 898.
46. Cederberg J et al. Combined treatment with vitamin E and vitamin C decreases oxidative stress and improves fetal outcome in experimental diabetic pregnancy. Pediatr Res 2001 49 : 755 762.
47. Collins M et al. Amelioration of the embryotoxicity of hydroxyurea in whole embryo culture with antioxidant substances. Teratology 1991 43 : 417.
48. Herken R. The influence of deoxycytidine monophosphate (dCMP) on the cytotoxicity of hydroxyurea in the embryonic spinal cord of the mouse. Teratology 1984 30 : 83 90.
49. DeSesso JM, Goeringer G. The nature of embryoprotective interaction of propylgallate with hydroxyurea. Reprod Toxicol 1990 4 : 145 152.
50. DeSesso JM, Goeringer G. Ethoxyquin and nordhydroguaiaretic acid reduce hydroxyurea developmental toxicity. Reprod Toxicol 1990 4 : 160 167.
51. DeSesso JM et al. Hydroxylamine moiety of developmental toxicants is associated with early cell death: a structure-activity analysis. Teratology 2000 62 : 346 355.
52. Pérez-Pastén R et al. Effects of dimethylsulphoxide on mice arsenite-induced dysmorphogenesis in embryo culture and cytotoxicity in embryo cells. Toxicol Lett 2006 161 : 167 173.
53. Keysar SB et al. Hypoxia/reoxygenation-induced mutations in mammalian cells detected by the flow cytometry mutation assay and characterized by mutant spectrum. Radiat Res 2010 173 : 21 26.
54. Okada Y et al. Hydroxyl radical scavenging action of capsaicin. Redox Rep 2002 7 : 153 157.
55. Heo H et al. Effect of antioxidant flavanone, naringenin, from Citrus junoson neuroprotection. J Agric Food Chem 2004 52 : 1520 1525.
56. Boots A et al. Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol 2008 585 : 325 337.
57. Di Giorgio A et al. Dimethyl sulfoxide provides neuroprotection in a traumatic brain injury model. Restor Neurol Neurosci 2008 26 : 501 517.